Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.63 USD | -1.99% | +4.75% | -13.26% |
05-07 | Beam Therapeutics Shares Fall After Q1 Revenue Misses Estimates | MT |
05-07 | Beam Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.26% | 1.9B | |
+33.33% | 49.46B | |
+1.76% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.57% | 26.61B | |
-22.67% | 18.64B | |
+8.22% | 13.16B | |
+29.58% | 12.55B | |
+24.25% | 12.1B |
- Stock Market
- Equities
- BEAM Stock
- News Beam Therapeutics Inc.
- Barclays Adjusts Price Target on Beam Therapeutics to $41 From $45, Keeps Equalweight Rating